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Commentary: Depression and Diabetes Distress 
Type 2 diabetes is associated with a two-fold increase in clinical 
depression compared to the general population [1].   Depression in type 
2 diabetes is associated with serious consequences including poor 
metabolic control [2], higher mortality rates [3] and possibly, increased 
risk of macro- and micro-vascular complications [4,5].  
 
Meta-analytic studies have found evidence that the relationship 
between diabetes and depression is reciprocal with depression 
increasing the risk of incident type 2 diabetes [6] and type 2 diabetes 
increasing the risk of developing a depressive episode [7].  Although the 
underlying mechanisms remain poorly understood, both diabetes and 
depression may be driven by common biological factors including 
hypothalamic-pituitary-adrenal axis activation [8] and inflammation 
[9,10].   
 
While contributing to depression, shared biological factors do not fully 
explain the relationship between diabetes and depression.  For example, 
epidemiological studies have shown that, compared to the general 
population, the prevalence of depression was increased in people with 
diagnosed diabetes but not in those with undiagnosed diabetes (i.e. 
people who have diabetes but are unaware of having the condition) 
[11]. Also, depression is also more prevalent in people with T2DM who 
also have diabetes complications, but not in those without complications 
[12] suggesting that when the burden of diabetes increases, so do 
depression levels. In a recent study from the English Longitudinal Study 
of Aging (ELSA) database, Demakakos et al. [13] found higher incident 
depressive symptoms in younger older adults with diabetes than their 
non-diabetic counterparts (<65 years) but not in those 65 years and 
older.   
 
The above studies show that the presence of type 2 diabetes alone is not 
sufficient to increase the prevalence or incidence of depression. Rather, 
they suggest that depression in diabetes is linked to the burden of living 
with and having to care for diabetes especially in the presence of 
diabetes complications and the stresses of a working life.  
 
In this context, the concept of ‘diabetes distress’ has received increased 
attention.  Defined as ‘the concerns and worries about diabetes and its 
management’, diabetes distress has strong longitudinal associations with 
poor glycaemic control, poor self-care and high depressive symptoms, 
especially when self-reported [14,15].  This has led to suggestions that 
depressive symptoms in diabetes may be more reflective of general and 
diabetes-specific distress than of major psychopathology [16,17].  
However, there is considerable confusion regarding the relationship 
between depressive symptoms and diabetes distress.  
 
In this issue of Diabetic Medicine, two papers tackled this problem by 
examining the longitudinal relationship between diabetes distress and 
depressive symptoms.  In the first study from Germany, including more 
than 500 patients (66% Type 1 diabetes) on intensified insulin therapy, 
Ehrmann et al. assessed depressive symptoms using the CES-D 
questionnaire [18] and diabetes distress using the Problem Areas In 
Diabetes (PAID; [19]) questionnaire, at two time points, 6 months apart.  
 
Through a series of regression analyses, Ehrmann et al. showed that 
having more difficulty living with diabetes (higher diabetes distress) 
predicts more depressive symptoms 6-month later.  Inversely, having 
more depressive symptoms at baseline predicted more diabetes distress 
at the 6-moths follow-up.  The results did not change after controlling 
for baseline levels of depressive symptoms or diabetes distress, 
respectively. These results showed that there is a bi-directional 
relationship between depressive symptoms and diabetes distress.  
Ehrmann et al. also found that people reporting high levels of depressive 
symptoms and distress at baseline remained depressed at the 6-month 
follow-up suggesting that diabetes distress is implicated in the 
persistence of depressive symptoms.  However, high levels of diabetes 
distress at baseline along with depression did not significantly predict 
persistence of distress at follow-up. 
 
In the second study, Burns et al. followed-up a cohort of almost 1,700 
community-dwelling people with type 2 diabetes from Quebec, Canada 
at three occasions, one year apart.  Depressive symptoms (Patient 
Health Questionnaire, PHQ-9; [20]) and diabetes distress (Diabetes 
Distress Scale, [21]) were assessed at each time point along with a 
number of demographic and illness-related covariates. Using a cross-
lagged path model analysis and controlling for auto-regressive effects, 
Burns et al. not only confirmed that the relationship between depressive 
symptoms and diabetes distress was bi-directional but also that they 
were reciprocally related. More specifically, diabetes distress was 
associated with both concurrent and subsequent depression, which, in 
turn, was associated with concurrent and subsequent diabetes distress. 
The results suggest that when people are distressed about their diabetes 
they are more likely to experience subsequent depressed mood.  The 
findings also show that depressed mood is associated with subsequent 
perceptions of diabetes as a distressing experience.  
 
Overall, using different measures and samples, these two studies show 
that there is an intricate reciprocal relationship between depressive 
symptoms and diabetes distress. They provide support for the notion 
that depression in diabetes should be considered in the context of living 
with and having to care for this chronic condition.  However, because of 
their correlational nature, causal links between diabetes distress and 
depression cannot be assumed.   
 
In a recent report of a RCT specifically targeting diabetes regimen 
distress, latent growth model tests indicated that changes in distress co-
varied with changes in depressive symptoms, but that these changes 
were not causally related.  This suggests there are unmeasured 
underlying variables associated with both diabetes distress and 
depression [22]. It was proposed that diabetes regimen distress and 
depressive symptoms both reflected the latent construct of ‘emotional 
distress’, with the distress measure indicating the origins of the distress 
and depressive symptoms its severity.  However, considering the 
reciprocity of depressive symptoms and diabetes distress, shown in the 
Ehrmann et al. and Burns et al. papers, the origins of the underlying 
‘emotional distress’ concept linked to diabetes remains unclear.  
 
It is important to be mindful that there is more than one underlying 
process contributing to depression (whether based on diagnostic 
interviews or by self-report) with cognitive, behavioural and 
environmental events interacting with diabetes-related factors.  Low 
response-contingent positive reinforcement [23, 24] and disruptions of 
daily life due to diabetes and its consequences can reduce pleasure or 
enjoyment from valued activities contributing to depressive symptoms 
[25].  Stressful life events, including those related to diabetes [27] can 
trigger depression in people with pre-existing cognitive biases and 
distortions [26]. Research has also shown longitudinal associations 
between poor sleep, depression and stress [28] and between diabetes 
and poor sleep [29].  
 
Although the epidemiological literature shows little support for a 
biological explanation for the incidence of depression in diabetes, 
biological factors related to diabetes are likely to interact with the above 
mentioned psychological processes. Current research, with a 
predominance of cross-sectional studies, has barely begun to 
disentangle these underlying interactions, which may have important 
implications for the treatment of depressed mood in people with 
diabetes.   
 
While RCT studies have shown that targeting diabetes distress result in 
lower levels of depressive symptoms, they did not succeed in reducing in 
HbA1c or inflammatory markers [30,31]. Given the adverse effects of 
hyperglycaemia on brain functioning and synaptic plasticity [32, 33, 34], 
interventions should not neglect to simultaneously target glycaemic 
control.   
 
Arie Nouwen 
Associate Editor 
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